Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
297.4 USD | -0.37% | -2.19% | +3.58% |
12:30pm | RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating | MT |
06-13 | Race Oncology Validates Efficacy of Blood Cancer Therapy in Animal Study; Shares Rise 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.58% | 160B | |
+50.97% | 795B | |
+42.16% | 627B | |
-7.62% | 350B | |
+18.35% | 328B | |
+7.30% | 294B | |
+17.85% | 245B | |
+1.02% | 222B | |
+11.78% | 215B | |
-4.29% | 157B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Amgen's Imdelltra Gets US FDA Accelerated Approval for Drug to Treat Extensive Stage Small Cell Lung Cancer